I find it very hard to believe at (2) and/or (3) are done, and just waiting up-list. Can anyone make a convincing argument? It would seem to me that those would be material events that happen independently and have to be reported within specific time frames.
My belief is that they are working through, possibly on the brink of rejection to NASDAQ, and putting together data for the next FDA meeting to get through to phase 3. If there is a partnership in the wings, it's hinging on the results of that meeting. NASDAQ is great and all, but mostly meaningless compared to the other stuff.
If I'm a betting man, I think they'll get rejected from Nasdaq, granted P3 for B with less designations than our desires, and not have any news of a partnership. I am hoping for much better. I also hope that Dana-Farber publishes information about K that rocks our world.
Something happened - which unleashed the power of our imagination...